APA (7th ed.) Citation

Guy-Young, Kaan-Kavakli, W-Pipe, S., Alok-Srivastava, Juliana-Aragao, A-Menapace, L., . . . Gili-Kenet. (2024, October). SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE). Hematology, Transfusion and Cell Therapy.

Chicago Style (17th ed.) Citation

Guy-Young, et al. "SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE)." Hematology, Transfusion and Cell Therapy Oct. 2024.

MLA (9th ed.) Citation

Guy-Young, et al. "SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE)." Hematology, Transfusion and Cell Therapy, Oct. 2024.